From the drug target prediction, GO and pathway enrichment analysis and pharmacology networks analyses, we suggested that the anti-cancer effects of SO on HCC might be related to regulate cancer cell proliferation and survival via pathways including EGFR, PI3K/AKT, NFκB and MAPK signaling pathways. The gene discussed is EGFR; the disease is hepatocellular carcinoma.